Feed Preview

Tau Toxicity in the Synapses

Tau Toxicity in the Synapses diagram by nobeastsofierce, Shutterstock
nobeastsofierce, Shutterstock

Tau toxicity has been implicated in the emergence of synaptic dysfunction in Alzheimer's disease. Here is the latest research on Tau Toxicity in the Synapses.

Top 20 most recent papers
Nature Medicine

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

Nature MedicineMarch 13, 2020
Nicolas R BarthélemyDominantly Inherited Alzheimer Network
70
3
The Journal of Physical Chemistry. B

Tau R3-R4 Domain Dimer of the Wild Type and Phosphorylated Ser356 Sequences. I. In Solution by Atomistic Simulations

The Journal of Physical Chemistry. BMarch 29, 2020
Philippe DerreumauxPhuong Hoang Nguyen
Nature Reviews. Neurology

Protein transmission in neurodegenerative disease

Nature Reviews. NeurologyMarch 24, 2020
Chao PengVirginia M-Y Lee
67
1
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring

Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease

Alzheimer's & Dementia : Diagnosis, Assessment & Disease MonitoringMarch 27, 2020
Kunal DhimanRalph N Martins
Acta Neuropathologica Communications

Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series

Acta Neuropathologica CommunicationsMarch 29, 2020
H GeutW D J van de Berg
Analytical Biochemistry

Biomolecular condensates in cell biology and virology: phase-separated membraneless organelles (MLOs)

Analytical BiochemistryMarch 21, 2020
Pravin B SehgalJoseph D Etlinger
11
1
bioRxiv

FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau fibers

bioRxivMarch 25, 2020
Senthilvelrajan KaniyappanEckhard Mandelkow
18
Journal of Neuroinflammation

Role of dietary fatty acids in microglial polarization in Alzheimer's disease

Journal of NeuroinflammationMarch 27, 2020
Smita Eknath Desale, Subashchandrabose Chinnathambi
2
1
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring

Biomarker potential of brain-secreted extracellular vesicles in blood in Alzheimer's disease

Alzheimer's & Dementia : Diagnosis, Assessment & Disease MonitoringMarch 27, 2020
AmanPreet Badhwar, Arsalan S Haqqani
14
Saudi Journal of Biological Sciences

Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators

Saudi Journal of Biological SciencesMarch 27, 2020
Richard L JayarajRami Beiram
2
Science Advances

The mechanism of Hsp90-induced oligomerizaton of Tau

Science AdvancesMarch 24, 2020
S WeickertM Drescher
14
6
Molecular Diversity

A system-level approach to investigate alloxan-induced toxicity in microtubule-binding protein to lead type 2 diabetes mellitus

Molecular DiversityMarch 29, 2020
Paramashivam Sathish Kumar, Narayanan Dhiraviam Kannan

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/tau-toxicity-in-the-synapses/cdd881a9-f241-4cd7-9cd4-a56c0bdb1aba